Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
THR/RXR Heterodimer Assay for Thyroid Hormone Receptor Agonist Screening from US Patent US20240059682: "THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS"
Assay data:26 Active, 25 Activity ≤ 1 µM, 26 Tested
SummaryRelated BioAssays by Target
Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for Thyroid Hormone Receptor Agonist Screening from US Patent US20240059682: "THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS"
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
THR Reporter Gene Method from US Patent US20240059676: "THYROID HORMONE RECEPTOR b SELECTIVE AGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF"
Assay data:32 Active, 21 Activity ≤ 1 µM, 38 Tested
MCF-7 Cell Growth Study from US Patent US20240043442: "SELECTIVE ESTROGEN RECEPTOR DEGRADERS AND USES THEREOF"
Assay data:50 Active, 30 Activity ≤ 1 nM, 50 Activity ≤ 1 µM, 50 Tested
Human PPARalpha Reporter Assay from US Patent US20240041837: "TRIAZOLONE COMPOUNDS AND USES THEREOF"
Assay data:29 Active, 24 Activity ≤ 1 µM, 29 Tested
Cross screening panel
Assay data:1 Tested
Safety47 Scan (DiscoverX - Eurofins)
Progesterone PR-B Eurofins Panlabs panel
Glucocorticoid Eurofins Panlabs panel
Estrogen Eralpha Eurofins Panlabs panel
Androgen (Testosterone) Eurofins Panlabs panel
GCORTICOID/H Eurofins SafetyScreen44 (BI)
ANDROGEN/H Eurofins SafetyScreen44 (BI)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on